CHOLELITHIASIS IN PATIENTS AFTER BARIATRIC SURGERY: LITERATURE REVIEW
DOI:
https://doi.org/10.66104/k7tssa54Keywords:
obesity; cholelithiasis; bariatric surgeryAbstract
Obesity is characterized by excessive accumulation of body fat capable of impairing health and is classified according to body mass index (BMI) into normal weight (18–24.9 kg/m²), overweight (25–29.9 kg/m²), and grade I to III obesity (≥30 kg/m²). Since 1975, its global prevalence has tripled, affecting more than 1 billion people worldwide. Bariatric surgery is an effective therapeutic alternative for patients refractory to conservative treatments. Non-neoplastic biliary disease, including cholelithiasis, is a frequent complication in the postoperative period following bariatric surgery, resulting from multiple lithogenic mechanisms such as rapid weight loss, increased release of cholesterol and lipids from adipocytes, and reduction of preoperative BMI ≥25%. The aim of this study was to analyze, through a literature review, the relationship between non-neoplastic biliary disease and obesity, emphasizing risk factors, pathophysiological mechanisms, and the indication of concomitant cholecystectomy during bariatric surgery. Twenty articles published from 2003 onwards were selected from PubMed, SciELO, and LILACS databases using the descriptors bariatric, cholelithiasis, and obesity. The incidence of post-bariatric cholelithiasis ranged from 1.4% to 55.5%, with higher risk observed in women, patients with rapid weight loss, multiparity, or use of oral contraceptives. Protective factors include advanced age, statin use, and prophylaxis with ursodeoxycholic acid. Cholelithiasis tends to occur within the first six months after surgery and is more frequent after gastric bypass. Concomitant cholecystectomy is considered safe and is especially indicated for patients with preexisting gallstones.
Downloads
References
AGUIAR, R. G. P. de et al. Clinical and epidemiological evaluation of complications associated with gallstones in a tertiary hospital. Arquivos de Gastroenterologia, v. 59, n. 3, 2022. DOI: https://doi.org/10.1590/S0004-2803.202200000-59
ALDRIWEESH, Mohammed A. et al. The incidence and risk factors of cholelithiasis development after bariatric surgery in Saudi Arabia: a two-center retrospective cohort study. Frontiers in Surgery, v. 7, 2020. DOI: https://doi.org/10.3389/fsurg.2020.559064
ALSAIF, Faisal A. et al. Incidence of symptomatic cholelithiasis after laparoscopic sleeve gastrectomy and its association with rapid weight loss. Saudi Journal of Gastroenterology, 2020.
ANVEDEN, Asa et al. Long-term incidence of gallstone disease after bariatric surgery: results from the Swedish Obese Subjects study. Surgery for Obesity and Related Diseases, v. 16, p. 1474–1482, 2020. DOI:https://doi.org/10.1016/j.soard.2020.05.025
BOERLAGE, Thomas C. C. et al. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial). BMC Gastroenterology, v. 17, n. 1, 2017. DOI: https://doi.org/10.1186/s12876-017-0632-5
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Vigitel Brasil 2020: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico. Brasília: Ministério da Saúde, 2021.
BRASIL. Ministério da Saúde. Pesquisa Nacional de Saúde (PNS) 2020. Brasília: MS, 2020.
BRASIL. Ministério da Saúde. Sistema de Vigilância Alimentar e Nutricional (SISVAN). Brasília: MS, 2024.
CABRERA CHAMORRO, C. C. et al. Cholelithiasis and associated complications. Cirugía Pediátrica, v. 33, n. 2, 2020.
CARVALHO, M. R.; SANTOS, J. L. Diagnóstico por imagem das doenças biliares. Radiologia Brasileira, 2020.
COSTA, T. N.; FREITAS, A. C. Colecistectomia profilática em cirurgia bariátrica: revisão. Revista do Colégio Brasileiro de Cirurgiões, 2020.
COUPAYE, M. et al. Comparison of the incidence of cholelithiasis after sleeve gastrectomy and Roux-en-Y gastric bypass in obese patients: a prospective study. Surgery for Obesity and Related Diseases, v. 11, n. 4, p. 779–784, 2015. DOI: https://doi.org/10.1016/j.soard.2015.01.005
D’HONDT, M. et al. Laparoscopic sleeve gastrectomy as a single-stage procedure for the treatment of morbid obesity. Obesity Surgery, v. 21, n. 6, p. 722–727, 2011. DOI: https://doi.org/10.1007/s11695-010-0330-3
GERO, Daniel et al. Long-term incidence of gallstone disease after bariatric surgery. Annals of Surgery, v. 270, n. 5, p. 859–867, 2019. DOI: https://doi.org/10.1097/SLA.0000000000003504
GUMAN, M. S. S. et al. Adipose tissue, bile acids, and gut microbiome species associated with gallstones after bariatric surgery. Journal of Lipid Research, 2022. DOI: https://doi.org/10.1016/j.jlr.2022.100164
HAAL, Sylke et al. Risk factors for symptomatic gallstone disease and gallstone formation after bariatric surgery. Obesity Surgery, v. 32, n. 4, p. 1270–1278, 2022. DOI: https://doi.org/10.1007/s11695-021-05831-2
HAAL, Sylke et al. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE trial). The Lancet Gastroenterology & Hepatology, v. 6, n. 12, 2021. DOI: https://doi.org/10.1016/S2468-1253(21)00249-4
OLIVEIRA, C. I. B. et al. Impact of rapid weight reduction on risk of cholelithiasis after bariatric surgery. Obesity Surgery, v. 13, n. 4, 2003. DOI: https://doi.org/10.1381/096089203322190781
KIM, Hyung Sun et al. Big data analysis of risk factors for gallbladder disease in young adults. PLOS ONE, v. 14, n. 2, 2019. DOI: https://doi.org/10.1371/journal.pone.0211480
KUBICA, Krystian; BALBUS, Joanna. Cholesterol gallstone risk associated with obesity and normal weight. Scientific Reports, v. 11, 2021. DOI: https://doi.org/10.1038/s41598-021-81273-9
LEMOS, L. N.; TAVARES, R. M. F.; DONADELLI, C. A. D. M. Perfil epidemiológico de pacientes com colelitíase atendidos em ambulatório de cirurgia. Revista Eletrônica Acervo Saúde, v. 28, 2019. DOI: https://doi.org/10.25248/reas.e1230.2019
LIU, Tong et al. Relationship between high-sensitivity C-reactive protein and gallstone risk. BMJ Open, v. 10, n. 9, 2020. DOI: https://doi.org/10.1136/bmjopen-2020-037351
MACHADO, F. H. F. et al. Ursodeoxycholic acid in the prevention of gallstones in patients subjected to Roux-en-Y gastric bypass. Acta Cirúrgica Brasileira, v. 34, n. 1, 2019. DOI: https://doi.org/10.1590/s0102-865020190010000007
MOON, R. C. et al. Management of gallbladder disease in bariatric surgery. Surgery for Obesity and Related Diseases, v. 10, n. 3, p. 481–486, 2014. DOI: https://doi.org/10.1016/j.soard.2013.10.010
NGUYEN, N. T. et al. Bariatric surgery for obesity and metabolic disorders. Nature Reviews Gastroenterology & Hepatology, v. 14, n. 3, p. 160–169, 2016. DOI: https://doi.org/10.1038/nrgastro.2016.170
PATEL, K. et al. Association between obesity and gallstone disease: a systematic review. Cureus, v. 14, n. 1, 2022. DOI: https://doi.org/10.7759/cureus.21056
RODRIGUES, R. M. et al. Ursodeoxycholic acid in prevention of gallstones after bariatric surgery. Acta Cirúrgica Brasileira, 2018.
SHENG, B. et al. Weight and asymptomatic gallbladder stones in hypercholesterolemia. Lipids in Health and Disease, v. 19, n. 1, 2020. DOI: https://doi.org/10.1186/s12944-020-01348-8
SILVA, R. S. Complicações pós-operatórias em cirurgia bariátrica. Revista Brasileira de Cirurgia Digestiva, 2017.
SOUZA, A. C. Complicações da cirurgia bariátrica: revisão de literatura. Revista de Medicina, 2019.
SUN, H. et al. Factors influencing gallstone formation. Biomolecules, v. 12, n. 4, 2022. DOI: https://doi.org/10.3390/biom12040550
TORRES, O. J. M. et al. Prevalência ultrassonográfica de litíase biliar. Revista do Colégio Brasileiro de Cirurgiões, v. 32, n. 1, 2005.
TSIRLINE, V. B. et al. Frequency and timing of cholecystectomy after bariatric surgery. Surgery for Obesity and Related Diseases, v. 10, n. 2, 2014. DOI: https://doi.org/10.1016/j.soard.2013.09.006
VURAL, A. et al. Increased gallstone formation after sleeve gastrectomy and the preventive role of ursodeoxycholic acid. Acta Gastro-Enterologica Belgica, v. 83, 2020.
YUAN, S. et al. Obesity, type 2 diabetes, lifestyle factors, and risk of gallstone disease. Clinical Gastroenterology and Hepatology, 2021. DOI: https://doi.org/10.1016/j.cgh.2021.06.038
Downloads
Published
Issue
Section
License
Copyright (c) 2026 GEYZA CAROLINE OLIVEIRA PINTO PINTO, GUTEMBERG FERNANDES DE ARAÚJO
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
